Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Clinical trial NCT04435691 · TERMINATED
Trial details
- NCT number
- NCT04435691
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2025-03-25
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.